These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22283771)

  • 1. Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis.
    Durante A; Peretto G; Laricchia A; Ancona F; Spartera M; Mangieri A; Cianflone D
    Curr Pharm Des; 2012; 18(7):981-1004. PubMed ID: 22283771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiological role of tissue renin-angiotensin-aldosterone system (RAAS) in human atherosclerosis].
    Fukui K; Yamada H; Matsubara H
    Nihon Rinsho; 2012 Sep; 70(9):1556-61. PubMed ID: 23012803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD.
    Poznyak AV; Bharadwaj D; Prasad G; Grechko AV; Sazonova MA; Orekhov AN
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.
    Ferrario CM; Strawn WB
    Am J Cardiol; 2006 Jul; 98(1):121-8. PubMed ID: 16784934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New and old roles of the peripheral and brain renin-angiotensin-aldosterone system (RAAS): Focus on cardiovascular and neurological diseases.
    Mascolo A; Sessa M; Scavone C; De Angelis A; Vitale C; Berrino L; Rossi F; Rosano G; Capuano A
    Int J Cardiol; 2017 Jan; 227():734-742. PubMed ID: 27823897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases.
    Patel BM; Mehta AA
    Eur J Pharmacol; 2012 Dec; 697(1-3):1-12. PubMed ID: 23041273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammation and atherosclerosis: the role of Renin-Angiotensin system and its inhibition].
    Partigulova AS; Naumov VG
    Kardiologiia; 2010; 50(10):50-5. PubMed ID: 21118180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of poly (ADP-ribose)-polymerase and its signaling pathway with renin-angiotensin aldosterone system in renal diseases.
    Zhou TB; Jiang ZP
    J Recept Signal Transduct Res; 2014 Jun; 34(3):143-8. PubMed ID: 24303937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
    Rao MS
    J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease.
    Re RN
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):42-7. PubMed ID: 16265259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
    Horký K
    Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data.
    Hillaert MA; Lentjes EG; Beygui F; Kemperman H; Asselbergs FW; Nathoe HM; Agostoni P; Voskuil M; Ivanes F; Jude B; Bertrand ME; Pasterkamp G; van der Graaf Y; Doevendans PA; Montalescot G; Van Belle E
    Am Heart J; 2011 Oct; 162(4):585-96. PubMed ID: 21982648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data.
    Black HR
    Am Heart J; 2004 Apr; 147(4):564-72. PubMed ID: 15077068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and diabetes: role of the renin-angiotensin system.
    Jandeleit-Dahm K; Cooper ME
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease.
    Bernardi S; Michelli A; Zuolo G; Candido R; Fabris B
    J Diabetes Res; 2016; 2016():8917578. PubMed ID: 27652272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin-aldosterone system: a specific target for hypertension management.
    Weir MR; Dzau VJ
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies.
    Patel S; Rauf A; Khan H; Abu-Izneid T
    Biomed Pharmacother; 2017 Oct; 94():317-325. PubMed ID: 28772209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states.
    Brewster UC; Setaro JF; Perazella MA
    Am J Med Sci; 2003 Jul; 326(1):15-24. PubMed ID: 12861121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renin-aldosterone and bone metabolism].
    Ikeda K
    Clin Calcium; 2014 Jun; 24(6):885-91. PubMed ID: 24870840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulatory mechanisms for the renin-angiotensin-aldosterone system].
    Ichihara A
    Nihon Rinsho; 2012 Sep; 70(9):1477-81. PubMed ID: 23012790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.